US Stock MarketDetailed Quotes
PROK ProKidney
- 1.880
- +0.050+2.73%
Close Nov 26 16:00 ET
- 1.850
- -0.030-1.60%
Post 16:53 ET
240.58MMarket Cap-3481P/E (TTM)
1.950High1.790Low554.13KVolume1.830Open1.830Pre Close1.03MTurnover0.79%Turnover RatioLossP/E (Static)127.97MShares4.44052wk High-0.25P/B132.33MFloat Cap1.18052wk Low--Dividend TTM70.39MShs Float14.190Historical High--Div YieldTTM8.74%Amplitude1.120Historical Low1.850Avg Price1Lot Size
ProKidney Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -22.98%-29.24M | -156.72%-38.29M | -33.29%-34.65M | -16.84%-90.07M | -61.06%-25.38M | -4.09%-23.78M | 35.22%-14.92M | -68.14%-25.99M | -53.26%-77.09M | -21.33%-15.76M |
| Net income from continuing operations | 2.23%-41.05M | -10.46%-38.47M | 4.27%-35.33M | 8.57%-135.45M | 11.59%-21.72M | -23.70%-41.99M | -57.35%-34.82M | 45.31%-36.91M | -168.62%-148.14M | -79.76%-24.57M |
| Operating gains losses | 0.72%-1.66M | 6.92%-1.39M | -367.28%-2.29M | ---6M | ---2.34M | ---1.68M | ---1.49M | ---489K | ---- | ---- |
| Depreciation and amortization | 47.86%1.49M | 45.98%1.27M | 32.45%1.1M | 26.91%3.85M | 44.88%1.15M | 28.35%1.01M | 15.69%870K | 17.18%832K | 53.02%3.04M | 34.75%791K |
| Change In working capital | -104.57%-269K | -180.66%-7.52M | -137.49%-5.81M | 358.15%16.67M | 524.92%3.91M | 7.60%5.89M | 196.64%9.32M | -78.93%-2.45M | -398.48%-6.46M | -1,034.57%-919K |
| -Change in receivables | -131.93%-2.36M | 67.71%-844K | 90.34%-529K | ---1.38M | ---661K | --7.38M | ---2.61M | ---5.48M | --0 | ---- |
| -Change in prepaid assets | -181.99%-2.33M | -448.17%-6.73M | -83.81%564K | 164.28%4.65M | 68.61%-446K | 679.18%2.84M | 16.93%-1.23M | 190.63%3.48M | -26.77%-7.23M | 63.42%-1.42M |
| -Change in payables and accrued expense | 202.08%4.41M | -99.63%49K | -1,190.07%-5.84M | 1,635.88%13.4M | 898.41%5.01M | -359.89%-4.32M | 1,139.89%13.17M | -118.30%-453K | -90.19%772K | -86.80%502K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -22.98%-29.24M | -156.72%-38.29M | -33.29%-34.65M | -16.84%-90.07M | -61.06%-25.38M | -4.09%-23.78M | 35.22%-14.92M | -68.14%-25.99M | -53.26%-77.09M | -21.33%-15.76M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -187.71%-81.64M | 317.21%28.57M | 130.32%58.4M | -18,886.36%-329.98M | -31,221.57%-95.84M | -13,607.25%-28.37M | -3,307.51%-13.15M | -22,857.33%-192.61M | 66.52%-1.74M | 43.23%-306K |
| Net PPE purchase and sale | 91.40%-2.4M | 82.81%-636K | 2.64%-960K | -1,752.49%-34.2M | -413.73%-1.57M | -8,769.52%-27.94M | -858.55%-3.7M | -17.52%-986K | 64.44%-1.85M | 43.23%-306K |
| Net investment purchase and sale | -18,114.02%-79.23M | 408.96%29.21M | 130.98%59.36M | ---295.79M | ---94.27M | ---435K | ---9.45M | ---191.63M | --0 | --0 |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --108K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -187.71%-81.64M | 317.21%28.57M | 130.32%58.4M | -18,886.36%-329.98M | -31,221.57%-95.84M | -13,607.25%-28.37M | -3,307.51%-13.15M | -22,857.33%-192.61M | 66.52%-1.74M | 43.23%-306K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 34,376.92%4.46M | 1,075,807.69%139.84M | 0.00%-13K | -101.74%-9.55M | -118,800.00%-9.51M | -100.00%-13K | -100.08%-13K | -100.05%-13K | 667.48%548.52M | -100.03%-8K |
| Net issuance payments of debt | -7.69%-14K | 0.00%-13K | 0.00%-13K | -62.50%-52K | -62.50%-13K | 99.96%-13K | -100.09%-13K | -100.07%-13K | -6.67%-32K | 0.00%-8K |
| Net common stock issuance | --4.47M | ---- | ---- | ---9.5M | ---9.5M | --0 | ---- | ---- | --0 | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 667.21%548.55M | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 34,376.92%4.46M | 1,075,807.69%139.84M | 0.00%-13K | -101.74%-9.55M | -118,800.00%-9.51M | -100.00%-13K | -100.08%-13K | -100.05%-13K | 667.48%548.52M | -100.03%-8K |
| Net cash flow | ||||||||||
| Beginning cash position | -11.93%214.51M | -68.93%84.39M | -87.63%60.65M | 2,284.73%490.25M | -62.20%191.39M | 1,013.03%243.55M | 811.47%271.64M | 2,284.73%490.25M | 349.06%20.56M | 12,264.52%506.33M |
| Current changes in cash | -104.01%-106.42M | 563.35%130.12M | 110.86%23.74M | -191.46%-429.6M | -713.31%-130.74M | -110.77%-52.16M | -254.57%-28.08M | -2,464.96%-218.62M | 2,839.26%469.69M | -197.64%-16.08M |
| End cash Position | -43.52%108.09M | -11.93%214.51M | -68.93%84.39M | -87.63%60.65M | -87.63%60.65M | -62.20%191.39M | 1,013.03%243.55M | 811.47%271.64M | 2,284.73%490.25M | 2,284.73%490.25M |
| Free cash flow | 38.81%-31.65M | -109.12%-38.93M | -31.98%-35.61M | -57.43%-124.27M | -67.77%-26.96M | -123.32%-51.72M | 20.49%-18.62M | -65.53%-26.98M | -42.25%-78.94M | -18.75%-16.07M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data